Navi Medical Technologies Receives the US FDA’s 510(k) Clearance for Neonav ECG Tip Location System
Shots:
- Navi Medical has reported the US FDA’s 510(k) clearance for Neonav ECG Tip Location System to improve pediatric vascular care, with plans to raise capital & engage hospitals to expand access in the US market
- The system uses real-time ECG analysis to facilitate CVAD placement in pediatric pts, reducing misplacement & migration risks while also minimizing reliance on chest X-rays to provide immediate care to vulnerable patients
- Additionally, the system can be used to place tiny 1Fr catheters in very small neonates both above & below the heart with continuous surveillance after placement to prevent complications from undiagnosed catheter tip movement
Ref: Prnewswire | Image: Navi Medical Technologies
Related News:- Johnson & Johnson MedTech Launches Cereglide 92 Catheter System in the US for Acute Ischemic Stroke
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
